<?xml version="1.0"?>

<document>
	<title>A peroral test of pancreatic insufficiency with
   4-(N-acetyl-L-tyrosyl)aminobenzoic acid in children with cystic
   fibrosis.</title>

	<author>Malis-F.</author>
	<author>Fric-P.</author>
	<author>Kasafirek-E.</author>
	<author>Jodl-J.</author>
	<author>Vavrova-V.</author>
	<author>Slaby-J.</author>

	<source>J-Pediatr. 1979 Jun. 94(6). P 942-4.</source>

	<abstract>We report on the examination of stimulated pancreatic secretion using
   4-(N-acetyl-L-tyrosyl)aminobenzoic acid in children with cystic
   fibrosis.  In controls the urinary excretion of 4-aminobenzoic acid
   amounted to 54.8 +/- 11.7% with 19.6% as the lower limit of normal
   during six hours, and 74.7 +/- 10.8% and 40.5% during eight hours.
   In children with cystic fibrosis the mean values were 5.6% in the
   six-hour test and 13.7% in the eight-hour test.  Both values are
   significantly different in comparison with controls.  It may be
   assumed that both 4-(N-acetyl-L-tyrosyl)aminobenzoic acid and
   4-(N-benzoyl-L-tyrosyl)aminobenzoic acid are suitable for indirect
   determination of exocrine pancreatic secretion in children.</abstract>

	<majorsubject>P-AMINOBENZOIC-ACID: du</majorsubject>
	<majorsubject>AMINOBENZOIC-ACIDS: du</majorsubject>
	<majorsubject>CYSTIC-FIBROSIS: di</majorsubject>

	<minorsubject>P-AMINOBENZOIC-ACID: aa</minorsubject>
	<minorsubject>ADOLESCENCE</minorsubject>
	<minorsubject>CHILD</minorsubject>
	<minorsubject>CHILD-PRESCHOOL</minorsubject>
	<minorsubject>CYSTIC-FIBROSIS: pp</minorsubject>
	<minorsubject>FEMALE</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>MALE</minorsubject>
	<minorsubject>PANCREAS: pp</minorsubject>
	<minorsubject>TYROSINE: aa, du</minorsubject>

	<reference>001   IMONDI AR             GUT                             13   726 972</reference>
	<reference>002   GYR K                 GUT                             17    27 976</reference>
	<reference>003   ARVANITAKIS C         LANCET                           1   663 976</reference>
	<reference>004   BORNSCHEIN W          CLIN CHIM ACTA                  67    21 976</reference>
	<reference>005   NOUSIA-ARVANITAKIS S  J PEDIATR                       92   734 978</reference>
	<reference>006   MALIS F               J CLIN CHEM CLIN BIOCHEM        14   499 976</reference>
	<reference>007   MALIS F               ACTA HEPATOGASTROENTEROL        25   233 978</reference>
	<reference>008   SMITH HW              J CLIN INVEST                   24   388 945</reference>
	<reference>009   ZASSENHAUS PH         ANAL BIOCHEM                    76   321 976</reference>
	<reference>010   WOLGEMUTH RL          AM J DIG DIS                    21   821 976</reference>

	<citation>1   FRIC P                HEPATOGASTROENTEROLOGY          27   220 980</citation>
	<citation>2   NIESSEN KH            MONATSSCHR KINDERHEILKD        128   746 980</citation>
	<citation>3   SCHONBERGER W         MONATSSCHR KINDERHEILKD        128   195 980</citation>
	<citation>4   LANKISCH PG           HEPATOGASTROENTEROLOGY          28   333 981</citation>
	<citation>5   PARK RW               GASTROENTEROLOGY                81  1143 981</citation>
	<citation>6   NEIS P                MONATSSCHR KINDERHEILKD        129   347 981</citation>
	<citation>7   LANKISCH PG           GUT                             23   777 982</citation>
	<citation>8   KOLLBERG H            ACTA PAEDIATR SCAND SUPPL 301 1982    15 982</citation>
	<citation>9   LANKISCH PG           CLIN GASTROENTEROL              13   717 984</citation>
	<citation>10   SCOTTA MS             CLIN BIOCHEM                    18   233 985</citation>
	<citation>11   RIEU D                ANN PEDIATR (PARIS)             32   205 985</citation>
	<citation>12   CUMMING JGR           ARCH DIS CHILD                  61   573 986</citation>

</document>
